Skip to content

MaxABC study: effect of Automated Bolus Calculation on glycemic variability and relation with psychological problems. Pilot study.

MaxABC study: effect of Automated Bolus Calculation on glycemic variability and relation with psychological problems. Pilot study. - MaxABC study - Pilot

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON41020
Enrollment
20
Registered
2014-10-20
Start date
2014-11-10
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes

Interventions

study subjects will participate in the BolusCal education program: a structured program concerning insulin dose adjustment based on carbohydrate counting with the use of a personalized automated bol

Sponsors

Maxima Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: * Subject is * 18 years of age. * Patient is diagnosed with Type 1 or Type 2 diabetes, with an HbA1c in the range of 48-86 mmol/mol, with either multiple hypoglycemia episodes (defined as >1 per month) or large daily variability. HbA1c has remained stable within a range of 12 mmol/mol in the year prior to inclusion. * Subject has had diabetes for >12 months. * Subject has been on Multiple Daily Injections (MDI) insulin therapy for at least 6 months * Subject adjusts meal insulin doses based on carbohydrate content of meals. * Subject is sub-optimally controlled at investigator*s discretion.

Exclusion criteria

Exclusion criteria: * Subject has been diagnosed with any clinically significant condition at investigator*s discretion e.g. infectious disease, major organ system disease, Gastroparesis, Psychosis or cognitive impairment, severe or moderate renal impairment, defined by an eGFR

Design outcomes

Primary

MeasureTime frame
The purpose of the present study is to test whether a structured Bolus Calculation education program and subsequent use of the Accu-Chek® Aviva Expert with an integrated bolus advisor can improve glycemic control in carbohydrate counting-patients with type 1 or type 2 diabetes mellitus with suboptimal glycemic control. Additionally, we will asses if the BolusCal concept leads to improvements in various patient reported outcomes such as quality of life, treatment satisfaction and fear of hypoglycemia.

Secondary

MeasureTime frame
To determine if measurements of daily glucose levels are associated with psychological factors (mood, anxiety, energy level). And if so, which glucose measurements are related to which psychological factors To determine if, in case an association is found for the question above, the type of diabetes is an effect modificator. To determine if patients with depressive disorders and/or other long term psychological problems have greater glucose fluctuations or other differences in glucose measurements.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)